胰高血糖素样肽-1受体激动剂治疗2型糖尿病的临床疗效及安全性观察(3)
[3] 陈英，詹晓蓉，殷微微，等. 2型糖尿病患者早期使用胰高血糖素样受体激动剂[J].现代生物医学进展，2015， 15(11)：2195-2196.[4] Mima A，Hiraoka-Yamomoto J，Li Q，et al. Protective effects of GLP-1 on glomerular endothelium and its inhibition by PKCβ activation in diabetes[J]. Diabetes，2012， 61(11)：2967-2979.
[5] Rieg T，Gerasimova M，Murray F，et al. Natriuretic effect by exendin-4，but not the DPP-4 inhibitor alogliptin，is mediated via the GLP-1 receptor and preserved in obese type 2 diabetic mice[J]. Am J Physiol Renal Physiol ......
您现在查看是摘要页，全文长 3868 字符。